Abstract：
UNASSIGNED: Sepsis remains a complex and costly disease with high morbidity and mortality. This article discusses Sepsis-2 and Sepsis-3 definitions, highlighting the 2021 Surviving Sepsis International guidelines as well as the regulatory requirements and reimbursement for the Severe Sepsis and Septic Shock Management Bundle (SEP-1) measure.
摘要：
■脓毒症仍然是一种复杂而昂贵的疾病，发病率和死亡率都很高。本文讨论了脓毒症-2和脓毒症-3的定义，强调2021年幸存脓毒症国际指南以及严重脓毒症和脓毒症休克管理捆绑（SEP-1）措施的监管要求和报销。
